Address: Kortrijksesteenweg 1007
9000 Gent
Belgium
Tel: +32 9 233 48 66
Web: http://www.beapp.be/
The Belgian Association of Pharmaceutical Physicians (BeAPP) or Association belge des Médecins Pharmaceutiques (ABEMEP) or Belgische Vereniging van Farmaceutische Artsen (BEVEFA) is a non-profit organisation founded in 1972 by physicians employed in the Pharmaceutical Industry in Belgium.
BeAPP has endeavoured to portray the image of this profession, as favourably as possible, not just towards other physicians but also towards regulatory and academic institutions. This task can in no way be considered to be accomplished and will need to be continued indefinitely. Many medical practitioners are still unaware of the important role played by their colleagues within the Pharmaceutical Industry in domains as diversified as basic research, clinical development, registration, medical information and pharmacovigilance.
It is the task of BeAPP to heighten awareness of the important role of physicians in the continued search for newer and better medicines for the benefit of all patients.
Can you provide us with an overview of BeAPP’s missions & objectives and your role as President of the association? Stefaan Vancayzeele (SV): The primary mission of the Belgian association…
PharmaBoardroom was delighted to attend DIA Europe 2024 in Brussels earlier this month, bringing together a veritable who’s-who of the European and global regulatory community. The politicians, regulators, payers, patient…
Belgium, one of Europe’s most important countries for biopharmaceutical production and R&D, assumed presidency of the Council of the European Union on the first of January. As part of its…
A new piece in the January 2023 edition of DIA’s Global Forum magazine lays out how a new coalition aims to transform the landscape for rare disease treatments in Europe…
UCB has been undergoing a far-reaching digital business transformation, integrating novel approaches across its R&D organisation, including Computer-Aided Drug Design (CADD) and AI, while striving to maintain a patient-centric focus.…
Pfizer’s David Isom and Monica Mihedji, writing in the November 2023 edition of the DIA’s Global Forum magazine, examine how the European Medicines Agency is attempting to integrate the use…
Encircled by heavyweight life sciences powerhouses of the likes of Germany, France and Switzerland, plucky Belgium nonetheless continues to astonish and project considerable influence when it comes to its abilities…
The European Coalition for Access to Comprehensive Genomic Profiling (ECGP) is a new initiative made up of industry association the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), molecular diagnostics firms Exact…
Janssen has the lofty aim of reaching USD 60bn dollars in sales by 2025, an 8bn increase on the 2021 figure, despite some high-profile losses of exclusivity and the spin-off…
There have been both ups and downs in AbbVie’s recent history. After proving its staying power with the celebration of its 10-year anniversary as an independent company spun off from…
Representatives of Belgian associations for innovative pharma, generics and biosimilars, medtech, OTC, biotech, hospitals, and medical professionals share their key agenda priorities. These include where they feel that change is…
Germany and Belgium have long held an important trading relationship, says Margit Kunz of AHK Debelux, the German chamber of commerce in Belgium and Luxembourg. She outlines some of the…
Perhaps to the surprise of many, Belgium is the world’s second-largest producer of vaccines, behind only the US, and – capitalising on its years of experience in the field –…
See our Cookie Privacy Policy Here
